ATF4 activates a transcriptional program that chronically suppresses mTOR activity promoting neurodegeneration in Parkinson's disease models
Matthew D. DemmingsiD, Erica A. Kane, Elizabeth C. Tennyson, Kate Hurley, Joy L ZhaoiD, Nichola A. Cruickshanks, Victoria Ciz, Jordan M KrupaiD, Stephen PasternakiD, Sean P. Cregan
Abstract
The Integrated Stress Response (ISR) is a cell signaling pathway that enables cells to adapt to diverse cellular stresses. Conversely, during chronic/unmitigated cellular stress the ISR becomes maladaptive and has been implicated in a range of neurodegenerative conditions including Parkinsons Disease (PD). However, the mechanisms by which maladaptive ISR/ATF4 signaling contributes to neurodegeneration have not been elucidated. In this study we establish a critical mechanism by which chronic ISR activation becomes maladaptive and promotes neurodegeneration in neurotoxin and - synucleinopathy models of PD in vitro and in vivo. Specifically, we demonstrate that chronic activation of ATF4, the central transcription factor of the ISR, promotes neurodegeneration by regulating the transcriptional induction of SESN2, DDIT4 and Trib3 that co-operate to suppress both mTORC1 and mTORC2 activity. Furthermore, we demonstrate that ATF4-mediated suppression of mTORC1/2 activity promotes dopaminergic neuronal death in PD models by facilitating the activation of the pro- apoptotic BCL-2 family protein PUMA. Taken together, we have discovered a novel maladaptive ISR/ATF4 signaling pathway leading to chronic suppression of mTORC1/2 activity resulting in PUMA-mediated neuronal death that may have therapeutic implications in a range of neurodegenerative conditions that exhibit chronic ISR activation. O_FIG O_LINKSMALLFIG WIDTH=125 HEIGHT=200 SRC="FIGDIR/small/658667v1_ufig1.gif" ALT="Figure 1000"> View larger version (36K): org.highwire.dtl.DTLVardef@4fa02forg.highwire.dtl.DTLVardef@19d9f0forg.highwire.dtl.DTLVardef@13597beorg.highwire.dtl.DTLVardef@17d47e0_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ATF4 regulates neuronal death in models of Parkinson’s Disease
Matthew D. Demmings, Gillian N. Petroff, … Sean P. Cregan·bioRxiv·Sep 30, 2019
- ATF2 phosphorylation is a core transcriptional driver of neuron apoptosis
Jorge Gómez-Deza, Matthew Nebiyou, … Claire E. Le Pichon·NeuronPeer-reviewed·May 19, 2026
- Statins and genetic inhibition of the mevalonate pathway activate an ATF3-STMN2 regenerative program
Matthew Nolan, Sandeep Aryal, … Clotilde Lagier‐Tourenne·bioRxiv·Feb 24, 2026
- Enhanced mTORC1 signaling and Protein Synthesis in Parkinson Disease Pathogenesis
Mohammed Repon Khan, Xiling Yin, … Ted M. Dawson·bioRxiv·Oct 3, 2022
- Rationally Designed PKD1 Activator Protects Against Neurodegeneration in Pre-clinical Models of Parkinson's Disease
Arunkumar Asaithambi, Ah-Young Jang, … Anumantha G. Kanthasamy·bioRxiv·Feb 13, 2025
- α-synuclein over expression, NRF2 suppression, and enhanced ferroptosis creates a vicious cycle of neuronal loss in Parkinson's disease
Annadurai Anandhan, W Chen, … D.D. Zhang·bioRxiv·Jul 22, 2022